GALLANT 5 Tesaglitazar Versus Metformin
Public ClinicalTrials.gov record NCT00214591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-wk Randomised, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin) Study to Evaluate the Efficacy, Safety & Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 52-week randomized, double-blind, parallel-group, multi-center, active-controlled (metformin) study of tesaglitazar in patients with type 2 diabetes, not adequately controlled on diet and lifestyle advice alone during the run-in period. The study comprises a 6 week placebo single blind run in period followed by a 52-week a double blind treatment period and a 3-week follow-up period. Tesaglitazar and metformin will be titrated to optimal effect or highest tolerable dose during the first 12 weeks.
Study identification
- NCT ID
- NCT00214591
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 580 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2004 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Nov 19, 2010
2004 – 2006
United States locations
- U.S. sites
- 64
- U.S. states
- 28
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Columbiana | Alabama | — | — |
| Research Site | Mobile | Alabama | — | — |
| Research Site | Carlisle | Arizona | — | — |
| Research Center | Sherwood | Arizona | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Escondido | California | — | — |
| Research Site | Huntington Beach | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Mission Viejo | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Pasadena | California | — | — |
| Research Site | Pomona | California | — | — |
| Research Site | Redondo Beach | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Wheat Ridge | Colorado | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Brunswick | Georgia | — | — |
| Research Site | Carollton | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Evansville | Indiana | — | — |
| Research Site | Kansas City | Kansas | — | — |
| Research Site | Overland Park | Kansas | — | — |
| Research Site | Witchita | Kansas | — | — |
| Research Site | Bossier City | Louisiana | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Kalamazoo | Missouri | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Hamilton | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Pahrump | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | White Plains | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Kettering | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Simpsonville | South Carolina | — | — |
| Research Site | Morristown | Tennessee | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Menomonee Falls | Wisconsin | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00214591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2010 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00214591 live on ClinicalTrials.gov.